Market evolution: Cyclic amides (CN 29242970) — 2015–2025

Introduction

This report analyses the evolution of EU external trade in cyclic amides and cyclic carbamates (customs code 29242970) over the period 2017–2025. The product group falls under organic chemicals (HS 29) and encompasses a broad range of cyclic amide compounds used across pharmaceutical, agrochemical, and industrial applications. The EU is a net importer of these chemicals, with a persistent and widening trade deficit in value terms, even as import volumes have contracted. The period under review has been marked by significant price inflation, a reshaping of supply relationships with major trading partners, and substantial growth in domestic production. The report identifies three principal dynamics: a structural shift from volume-driven to value-driven trade, a significant reconfiguration of the EU's import supply base, and the growing importance of EU export markets in emerging economies.

I. The Great Decoupling: Surging Values Amid Contracting Volumes

The most striking feature of the EU's trade in cyclic amides over 2017–2025 is the divergence between trade values and trade volumes. Both exports and imports have seen their monetary value increase substantially while the physical quantities traded have simultaneously declined. This points to a structural increase in unit prices — driven by product mix changes, inflationary pressures, or supply-chain disruptions — rather than an expansion of the physical market.

Import values grew 41% while volumes fell 26%

According to the trade overview, EU imports of cyclic amides rose from €1,441 million in 2017 to €2,028 million in 2025, an increase of 40.7%. Over the same period, however, imported volumes fell from 53,203 tonnes to 39,488 tonnes, a decline of 25.8%. The minimum volume (35,849 tonnes) was recorded during this window, while the minimum value (€1,403 million) also fell below the 2017 figure, indicating that the value recovery followed a trough as well. The resulting unit price of imports more than doubled, rising from €27,079/tonne to €51,337/tonne (+89.6%).

Export values grew 22% while volumes fell 24%

EU exports followed a similar pattern, albeit with a smaller value increase. Export value rose from €403 million to €492 million (+22.1%), while volumes contracted from 8,510 tonnes to 6,486 tonnes (−23.8%). The peak export value reached €533 million. Export unit prices climbed from €47,298/tonne to €75,698/tonne (+60.0%), reflecting a shift toward higher-value-added products or price inflation in the downstream markets.

The trade deficit widened to €1.54 billion

Because imports are structurally much larger than exports — the EU is a net importer — the faster growth of import values has widened the trade deficit. The deficit in goods terms expanded from €1,038 million in 2017 to €1,536 million in 2025, an increase of 47.9%. The largest deficit recorded in the data window was €1,536 million (2025), while the smallest was €982 million. Despite this, the net import reliance actually declined from 70.6% to 54.3% (−23.2%), suggesting that EU domestic production has partially offset the volume decline in imports.

Domestic production more than doubled

The production volumes data reveals a significant expansion of EU manufacturing capacity. Output grew from approximately 9.5 million kg to 20.0 million kg (+111.6%), with a peak of 22.0 million kg. Production value rose even faster, from €432 million to €1,200 million (+177.8%), peaking at €1,200 million. This indicates that EU producers have not only scaled up volumes but have also benefited from — or contributed to — rising market prices.

II. A Reconfigured Import Supply Base: The Rise of Asia, the Decline of Traditional Partners

The EU's import structure for cyclic amides has undergone a fundamental transformation over the review period. While total import values have grown, the composition of supplying countries has shifted dramatically, with Asian suppliers — particularly China and India — gaining substantial market share at the expense of traditional European partners such as Switzerland and the United Kingdom.

China became the dominant supplier, growing 445%

The most dramatic shift has been the rise of China as an import source. Chinese exports to the EU surged from €146 million in 2017 to €796 million in 2025, an increase of 445.1%. China is now by far the largest single supplier, accounting for a major share of EU imports. The low coefficient of variation (0.104) for Chinese imports indicates that this growth has been remarkably steady rather than volatile.

Switzerland's share declined by 55%

Conversely, Switzerland, which was the largest supplier at the start of the period (€713 million), saw its exports to the EU fall to €317 million (−55.5%). Switzerland's peak was €713 million and its trough was €260 million, indicating a broad-based decline rather than a single shock. This suggests either a loss of competitiveness, restructuring of supply chains by Swiss-based producers, or a shift in production to lower-cost jurisdictions.

India tripled its exports to the EU

India emerged as a major supplier, growing from €88 million to €354 million (+302.9%). The peak Indian export value to the EU was €406 million. This growth is consistent with India's broader strategy of expanding its pharmaceutical and fine chemicals manufacturing base. However, Indian imports were subject to a notable price shock in 2019 (abnormality score: 8.8, price shift: +242.2%), which may have been linked to regulatory changes or supply disruptions.

The United Kingdom's exports collapsed by 92%

The most dramatic decline among partners was the United Kingdom, whose exports to the EU fell from €43 million to just €3.3 million (−92.4%). The extreme volatility (coefficient of variation: 1.164) and the near-total collapse strongly suggest that Brexit-related regulatory divergence, customs barriers, and supply chain reconfiguration have effectively severed this trade relationship.

Import concentration decreased, indicating diversification

The Herfindahl-Hirschman Index (HHI) for import value declined from 3,019 to 2,397 (−20.6%), moving from a moderately concentrated to a less concentrated market structure. The minimum HHI was 1,924. This is consistent with the diversification away from Switzerland toward multiple Asian suppliers, reducing the EU's dependence on any single source. The volume-based HHI rose slightly from 2,098 to 2,326 (+10.9%), suggesting that while the value distribution has diversified, the volume distribution may be somewhat more concentrated.

III. Export Market Expansion: Emerging Economies Drive EU Outward Trade

While the EU's import side has been reshaped by Asian competition, the export side has seen a different but equally significant transformation. EU exporters have increasingly pivoted toward emerging and non-traditional markets, with particularly strong growth in shipments to the Russian Federation, Japan, Brazil, and the United States. This export diversification has contributed to a modest increase in total export value despite declining volumes.

The United States remained the top export destination

The United States was the EU's largest export market throughout the period, with shipments rising from €106 million to €210 million (+98.5%). The peak was €262 million. US-bound exports were also subject to a major price shock in 2019 (abnormality: 245.9, price shift: +167.1%), which accounted for 46.2% of export value that year. This was the most significant single shock event in the entire dataset and may reflect a supply disruption or a strategic pricing decision by EU exporters.

The Russian Federation saw the fastest growth

EU exports to the Russian Federation grew from €5.2 million to €39.5 million (+665.8%), the highest percentage growth of any major partner. The peak was €40.2 million. This growth occurred despite — or perhaps because of — geopolitical tensions and sanctions regimes that have disrupted traditional supply chains, potentially creating opportunities for EU suppliers to fill gaps left by other exporters.

Japan and Brazil emerged as significant markets

EU exports to Japan more than tripled, rising from €17 million to €52 million (+201.3%). Brazil saw a similar trajectory, growing from €10 million to €34 million (+247.3%). Türkiye also grew strongly from €3.4 million to €9.6 million (+185.1%). These trends suggest that EU producers are finding growing demand in middle-income and developing economies for higher-quality or specialised cyclic amide products.

Italy and Ireland dominated EU production and specialisation

Within the EU, Italy showed the highest degree of specialisation (RSCA: 0.686, RCA: 5.37), accounting for 43.1% of EU production in this product category and 8.0% of total EU trade. Ireland was the second most specialised (RSCA: 0.464, RCA: 2.73), with 5.7% of production. Belgium (RSCA: 0.240, RCA: 1.63) held 13.8% of production share. At the other end, several smaller member states — Estonia, Lithuania, Croatia, Portugal, and Luxembourg — showed negligible or zero specialisation in this product group, indicating a highly concentrated production base within the EU.

Export concentration increased slightly

The export HHI by value rose from 1,588 to 2,147 (+35.2%), indicating that EU exports have become somewhat more concentrated in fewer destination markets. The volume-based HHI also increased from 1,238 to 1,459 (+17.8%). While these levels remain below the threshold for high concentration (2,500), the trend suggests that the growth of exports to a few key markets — notably the US and Japan — has outpaced the diversification of the overall export portfolio.

Conclusion

The EU trade in cyclic amides (CN 29242970) over 2017–2025 has been characterised by a fundamental shift from volume-driven to value-driven trade. Despite declining physical volumes in both imports (−25.8%) and exports (−23.8%), monetary values rose substantially (+40.7% and +22.1% respectively), driven by unit price increases of 89.6% and 60.0%. The trade deficit widened to €1,536 million, but the EU's net import reliance fell from 70.6% to 54.3%, as domestic production more than doubled in volume terms.

The import supply base has been reconfigured, with China (now the dominant supplier at €796 million, +445%) and India (+303%) displacing Switzerland (−55%) and the UK (−92%). This has reduced import concentration (HHI down 20.6%) but has also increased exposure to Asian supply chains. On the export side, the EU has successfully pivoted toward emerging markets, with dramatic growth in shipments to the Russian Federation (+666%), Japan (+201%), Brazil (+247%), and the United States (+99%).

The data points to a market in structural transition: one where the EU is increasingly a producer of higher-value cyclic amide products while relying on Asian suppliers for volume, and where export growth is being driven by non-traditional partners in a more geographically diversified portfolio. The price shocks detected in US-bound exports (2019) and Indian imports (2019) highlight the vulnerability of this market to sudden supply or pricing disruptions. Going forward, the sustainability of this value-focused strategy will depend on the EU's ability to maintain its technological edge in specialised products while managing the risks associated with an increasingly concentrated and price-sensitive import base.